Company / Revenue per Share
Arcturus Therapeutics Holdings Inc. Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$3.04
FY2025
5-year range
$0.47 / $6.28
FY2021-FY2025
Trend
-46.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $6.28 to $3.04 over the past 2 years.
Based on SEC 10-K filings.
3.04 in FY2025 with a 5-year CAGR of +23.9%.
Declined from $6.28 to $3.04 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +86.5%
- 5-Year CAGR
- +23.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 46.5% year-over-year.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.04 | -46.5% |
| FY2024 | $5.68 | -9.6% |
| FY2023 | $6.28 | +1240.3% |
| FY2022 | $0.47 | -0.7% |
| FY2021 | $0.47 | -54.7% |
| FY2020 | $1.04 | -29.2% |
| FY2019 | $1.47 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026